89BIO, INC. (ETNB): Price and Financial Metrics
ETNB Price/Volume Stats
| Current price | $8.29 | 52-week high | $11.84 |
| Prev. close | $8.02 | 52-week low | $4.16 |
| Day low | $7.78 | Volume | 485,095 |
| Day high | $8.45 | Avg. volume | 2,279,547 |
| 50-day MA | $7.71 | Dividend yield | N/A |
| 200-day MA | $8.25 | Market Cap | 1.21B |
ETNB Stock Price Chart Interactive Chart >
89BIO, INC. (ETNB) Company Bio
89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.
ETNB Price Returns
| 1-mo | 22.00% |
| 3-mo | -13.65% |
| 6-mo | -9.30% |
| 1-year | -5.26% |
| 3-year | 282.03% |
| 5-year | -64.95% |
| YTD | 6.01% |
| 2024 | -29.99% |
| 2023 | -12.25% |
| 2022 | -2.60% |
| 2021 | -46.37% |
| 2020 | -7.30% |
Loading social stream, please wait...